Leaderboards/immune cells in cancer

immune cells in cancer

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Anna C. Obenauf
Research Institute of Molecular Pathology
80
2
Yinghua Zhu
Sun Yat-sen University
70
3
Hai Hu
Zhejiang Cancer Hospital
60
4
Xiaojing Chu
Beijing Normal University
50
5
Zemin Zhang
Peking University
20
6
Yanlin Zhu
Harbin Engineering University
10

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Michelli F. Oliveira
10X Genomics (United States)
99
2
Tianyu Cao
National Clinical Research Center for Digestive Diseases
99
3
Barzin Y. Nabet
Genesys (United States)
90
4
Anais Elewaut
Research Institute of Molecular Pathology
90
5
Philippa Meiser
Technical University of Munich
80
6
Yue Zeng
Central South University
70
7
Raymond J. Lim
University of California, Los Angeles
40
8
Sijin Cheng
Peng Cheng Laboratory
40
9
Zedao Liu
Peking University
30
10
Chunliu Huang
Sun Yat-sen University
20

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Jérôme Galon
Délégation Paris 5
99
2
Ash A. Alizadeh
California Institute for Regenerative Medicine
90
3
Caetano Reis e Sousa
The Francis Crick Institute
80
4
Kenya Honda
RIKEN Center for Integrative Medical Sciences
70
5
Katey S.S. Enfield
The Francis Crick Institute
60
6
Robert H. Vonderheide
Cancer Research Institute
60
7
David Gfeller
SIB Swiss Institute of Bioinformatics
50
8
Adam J. Schoenfeld
Memorial Sloan Kettering Cancer Center
50
9
Victor E. Velculescu
Bloomberg (United States)
40
10
Bernd Bodenmiller
ZHAW Zurich University of Applied Sciences
30

All-Time Leaders Papers

1
High grade serous ovarian carcinomas originate in the fallopian tube
Nature Communications|2017
753 cit.
2
Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
Cancer Immunology Research|2015
467 cit.
3
Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection
The Journal of Experimental Medicine|2009
454 cit.
4
Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence
Cancer Research|2009
301 cit.
5
Nucleic acid agonists for Toll‐like receptor 7 are defined by the presence of uridine ribonucleotides
European Journal of Immunology|2006
280 cit.
6
Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity
PLoS Computational Biology|2017
272 cit.
7
Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer
Cancer Cell|2024
246 cit.
8
In-Depth Characterization of Monocyte-Derived Macrophages using a Mass Cytometry-Based Phagocytosis Assay
Scientific Reports|2019
193 cit.
9
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer
Clinical Cancer Research|2021
178 cit.
10
Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis
The Journal of Experimental Medicine|2020
175 cit.

Reagents for immune cells in cancer

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Proteintech

ChromoTek PD-1 VHH, recombinant binding protein for 2x Cys conjugation

Cited in 41 papers
#pd1Cys2$709
View Evidence →Proteintech

CoraLite® Plus 647-conjugated PD-1 VHH

Cited in 41 papers
#CL647-pd1$449
View Evidence →Proteintech

anti-IL6 recombinant VHH, for 1x Cys conjugation

Cited in 37 papers
#IL6Cys1$709
View Evidence →

🌟 All-Time

Most validated

Miltenyi Biotec

MHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, PE

Cited in 50 papers
#130-136-356
View Evidence →Miltenyi Biotec

MHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, Vio667

Cited in 50 papers
#130-135-297
View Evidence →Proteintech

CoraLite® Plus 555-conjugated PD-1 VHH

Cited in 41 papers
#CL555-pd1$449
View Evidence →